Nicholas Melchiorre’s Post

🤔 Did you know that obesity and alcohol consumption may be linked to an increase in colorectal cancer deaths in young adults? 😱 According to a recent study published in the Journal of the National Cancer Institute, the combination of #obesity and heavy alcohol use may be contributing to the rising number of #colorectal cancer deaths in young adults. The study found that young adults who were obese and drank heavily were at a higher risk of developing colorectal cancer and dying from the disease. This is a concerning trend, as colorectal cancer is typically considered a disease that affects older adults. So, if you're a young adult who is overweight or obese and enjoys #drinking, it's important to be aware of your risk and take steps to reduce your chances of developing colorectal cancer. 💪🏼👍 https://lnkd.in/eKhRt7sR

#mouthmatters On this #WorldCancerDay, let's address the critical issue of #oralcancer prevention. Amidst the broader cancer conversation, emphasizing proactive measures for oral health is paramount Oral cancer is the most common cancer in India amongst men (11.28% of all cancers), and the fifth most frequently occurring cancer among women (4.3% of all cancers) About 60% of oral cancer cases in India have a #five-year #survival rate, and this number has been shown to increase from 70 to 90 per cent with mere early detection in stages I and II https://lnkd.in/dkcinsKg #WorldCancerDay #OralHealthMatters #PreventOralCancer #ScreeningSavesLives #HealthyChoices #OralCancerAwareness #GlobalHealth #EarlyDetection #CancerPrevention #RaiseAwareness

The Get Data Out programme from the National Disease Registration Service released new data in April, including new detailed statistics on treatment and survival for cancer patients diagnosed between 2013 and 2020. Data has also been published on 2013-2020 incidence, treatment, and survival for the first time on the new site ‘Lung, mesothelioma, and other thoracic’. Patients with lung, mesothelioma, and other thoracic cancers have been divided into groups at https://lnkd.in/db6Zq-G7

Reflecting on International HPV Awareness Day, WITS DIH joins those seeking high-quality diagnostics to ensure that everyone, but particularly women in LMICs, has access to screening. HPV can be oncogenic and is particularly intricately linked to cervical cancer. Early detection can lead to decreased morbidity and mortality in line with global strategic goals. Read more about the WHO Global Strategy to accelerate the elimination of cervical cancer as a public health problem. https://bit.ly/4bZU2bw Wendy Susan Stevens Lara Noble Lesley Scott Lucia Hans Gillian Hunt Pascale Willem

🛑 Liver Cancer: What You Need to Know Liver cancer can develop silently, making it crucial to understand the causes and recognize symptoms early. 🌿 Whether it's due to chronic liver disease, hepatitis, or lifestyle factors, it's essential to stay informed. At Community Clinical Trials, we’re advancing research and providing the latest treatment protocols to combat this serious condition. The sooner we’re aware, the stronger our chances of successful intervention. 🩺 Learn more about the causes, symptoms, and the innovative treatments available to fight liver cancer. 👉 Stay informed: https://bit.ly/3B6vHD4 #LiverCancer #CancerAwareness #Health #LiverHealth #EarlyDetection #CancerTreatment #CommunityClinicalTrials

March is a month to raise awareness for both Colorectal and Kidney Cancer. Early detection saves lives! 🔍 Colorectal Cancer -It's the third most common cancer in both men and women. -Symptoms may include blood in the stool, changes in bowel habits, and abdominal discomfort. -Screening tests like colonoscopies can detect precancerous polyps before they become cancerous. 🔍 Kidney Cancer - It's among the top 10 most common cancers in both men and women. - Symptoms might include blood in the urine, back pain, or a lump in the abdomen. - Early diagnosis often leads to more successful treatment outcomes. 💡 Spread the word and encourage loved ones to get screened regularly. Awareness saves lives! #ColorectalCancerAwareness #KidneyCancerAwareness #EarlyDetectionSavesLives 🎗️

Prostate cancer (PC) is the most common cancer in men, affecting 3.3 million individuals in the United States in 2020. Although most patients present with localized disease at diagnosis, 1 in 9 have PC that will eventually progress to metastasis, with a 5-year survival rate of 34.1%. Visit JMCP to review a study in which it was determined that nearly two-thirds of men who advanced from stage IV prostate cancer to stage IV castration-resistant prostate cancer received substandard treatment before progression. Following disease progression, total health care costs were 1.5 to 2 times higher, and these men used more medical services, including hospital and outpatient visits. Access this article to gain a better understanding of the real-world economic burden of prostate cancer as it worsens: https://bit.ly/4fggoai #managedcare #healthcare #pharmacy #cancer #prostate

Happy New Year! Are you up to date with your routine health checks? According to the Australian Bureau of Statistics, most of us visit the GP only after we get sick, with many men aged 45-64 avoiding the doctor altogether. Of concern, only 36% of prostate cancers are detected at Stage 1 when the disease is easiest to treat. Proactive cancer checks significantly enhance survival rates across the spectrum of major cancers, including prostate cancer. If you or your loved one need more information on prostate cancer risks and early detection, call our team on 1800 22 00 99. Read more in Starts at 60's feature article here: https://lnkd.in/gXV6PRPr

Rare cancers are rare occurrences of a common disease affecting less than 6 per 100,000 individuals a year or one in five new patients diagnosed with cancer. Because of the rarity, we have to face multiple challenges in the care and understanding of this rare disease. Learn more about rare adult solid cancers on our website (link in our bio)! Follow EURACAN’s posts, and don’t hesitate to like or share!  #rarecancer #rarediseaseday #raredisease

Tumour markers are used to staging, define risk stratification, prognosis, monitor treatment response and detect disease relapse. They need to be measured before and after orchidectomy. Serum half-lives of AFP and β-hCG are five to seven days and one to three days respectively. If these remain elevated or increase metastatic disease is likely, although marker normalisation after orchiectomy does not exclude the possibility of metastatic disease. With follow-up, the precise frequency of testing is not well defined. This recommendation comes from the EAU Guidelines on Testicular Cancer, Edition 2024. #TesticularCancer #EAUguidelines Recommendations are posted daily on 'X' and weekly on LinkedIn. For more recommendations visit our website: https://lnkd.in/etFTcsnS